Skip to content

Safety evaluation

Safety confirmation studies of excessive intake of Collagen and barley young leaf processed food in healthy adult men and women. - Safety confirmation studies of excessive intake of Collagen and barley young leaf processed food in healthy adult men and women.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044377
Enrollment
10
Registered
2021-05-31
Start date
2021-06-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Sponsors

EP Mediate Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy adult men and women between the ages of 20 and 64.

Exclusion criteria

Exclusion criteria: (1) Subjects who are judged as unsuitable for this study by the principal investigator based on the results of clinical examination or cardiopulmonary abnormality (2) Subjects having possibilities for emerging allergy related to the study (3) Subjects having a disease requiring regular medication or a history of serious diseases for which medication was required (4) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (5) Subjects who have participated in other clinical studies (6) Subjects who intend to become pregnant or lactating (7) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (8) Subjects judged as unsuitable for the study by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Hematologic test Blood biochemistry test Urine analysis Blood pressure/pulsation Weight/body mass index Adverse event Evaluate at points of 2 week and 4 week of intake and 2 weeks after the end of ingestion period

Countries

Japan

Contacts

Public ContactKeiji Yamamoto

EP Mediate Co., Ltd. Development Business Headquarters, TTC Center, Trial Planning Department

yamamoto799@eps.co.jp03-5657-4983

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026